Whitehawk Therapeutics (WHWK) Current Leases (2019 - 2024)
Whitehawk Therapeutics (WHWK) reported Current Leases of $268000.0 for Q4 2024, down 38.25% year-over-year from $434000.0 in Q1 2024, and down 16.77% on a QoQ basis from $322000.0 in Q3 2024.
Whitehawk Therapeutics (WHWK) has 6 years of Current Leases data on file, last reported at $268000.0 in Q4 2024.
- Quarterly Current Leases fell 38.25% year-over-year to $268000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $268000.0 (down 38.25% YoY) and the FY2024 annual result came in at $268000.0, down 38.25% from the prior year.
- Current Leases declined to $268000.0 in Q4 2024 per WHWK's latest filing, from $322000.0 in the prior quarter.
- Across five years, Current Leases topped out at $434000.0 in Q4 2023 and bottomed at $9955.0 in Q2 2021.
- The 5-year median for Current Leases is $295000.0 (2024), against an average of $251285.0.
- The widest annual swing landed in 2021, when Current Leases plunged 91.04%; it then jumped 3154.65% in 2022.
- Tracing WHWK's Current Leases over 5 years: stood at $125000.0 in 2020, then rose by 4.8% to $131000.0 in 2021, then soared by 200.76% to $394000.0 in 2022, then rose by 10.15% to $434000.0 in 2023, then slumped by 38.25% to $268000.0 in 2024.
- Per Business Quant, the three latest WHWK Current Leases figures stand at $268000.0 (Q4 2024), $322000.0 (Q3 2024), and $374000.0 (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 268,000.00 |
| Sep 30, 2024 | 322,000.00 |
| Jun 30, 2024 | 374,000.00 |
| Mar 31, 2024 | 425,000.00 |
| Dec 31, 2023 | 434,000.00 |
| Sep 30, 2023 | 423,000.00 |
| Jun 30, 2023 | 413,000.00 |
| Mar 31, 2023 | 404,000.00 |
| Dec 31, 2022 | 394,000.00 |
| Sep 30, 2022 | 374,000.00 |
| Jun 30, 2022 | 324,000.00 |
| Mar 31, 2022 | 163,000.00 |
| Dec 31, 2021 | 131,000.00 |
| Sep 30, 2021 | 90,000.00 |
| Jun 30, 2021 | 9,955.00 |
| Mar 31, 2021 | 39,171.00 |
| Dec 31, 2020 | 125,000.00 |
| Sep 30, 2020 | 94,787.00 |
| Jun 30, 2020 | 111,053.00 |
| Mar 31, 2020 | 106,734.00 |
| Dec 31, 2019 | 102,555.00 |
| Sep 30, 2019 | 197,184.00 |
| Jun 30, 2019 | 193,284.00 |
| Mar 31, 2019 | 189,511.00 |